On 12/13/24, NovoCure Ltd (NASDAQ: NVCR) stock enjoyed a major increase of 11.1%, closing at $33.41. Moreover, this advance was accompanied by above average trading volume at 121% of normal. The stock has been strong relative to the market over the last nine months and has risen 25.6% during the last week.
Current PriceTarget Research Rating
NovoCure has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. NovoCure has a very low Appreciation Score of 7 but a slightly positive Power Rating of 64, triggering the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment